Zonguldak Bulent Ecevit University

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Follicular lymphoma3 trials
• Migraine2 trials
• Multiple sclerosis1 trial

Phase

• Phase 33 trials

Status

• Completed3 trials
• Active, not recruiting1 trial
• Recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Regeneron Pharmaceuticals3 trials
• Bozok University2 trials
• Zonguldak Bulent Ecevit University1 trial

Running trials

• Recruiting

  A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

  NCT06149286· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Active, not recruiting

  A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma

  NCT06097364· Phase 3· Regeneron Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Follicular lymphoma1 recruiting

Closed trials

• Completed

  Trunk Restraint in Multiple Sclerosis

  NCT06982833· Zonguldak Bulent Ecevit University· Source

• Completed

  Tampa Kinesiophobia Scale Modified for Headache

  NCT06857357· Bozok University· Source

• Completed

  Head Awareness in Chronic Migraine Patients

  NCT06857383· Bozok University· Source

• Recruiting

  A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

  NCT06091254· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator